Floatz logo

sc1011

Idiopathic Pulmonary Fibrosis

Guangzhou JOYO Pharma Co., LtdPhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
73/ 100

Competitive context

110 Active assets in the Idiopathic Pulmonary Fibrosis cohort.

Asset / SponsorPhaseRating
Pirfenidone
Endeavor Biomedicines, Inc.
Phase 4A
N-Acetyl-L-Cysteine
Endeavor Biomedicines, Inc.
Phase 4BBB
Nintedanib
Mannkind Corporation
Phase 4BBB
hsk44459
Haisco Pharmaceutical Group Co., Ltd.
Phase 3BB
PREDNISONE TABLETS
Fondation Hôpital Saint-Joseph
Phase 3BB

View all 50 →

Same molecule, other indications

sc1011 is also rated in:

pulmonary fibrosisDormant
CC
Indicative ·
46 / 100
View asset →
idiopathic pulmonary fibrosisDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →